Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  breast cancer, male breast cancer
Trial Type:  Screening, Prevention
Results 1-22 of 22 for your search:
Start Over
Metformin Hydrochloride in Preventing Breast Cancer in Patients with Atypical Hyperplasia or In Situ Breast Cancer
Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention
Age: 25 to 55
Trial IDs: A211102, NCI-2013-00995, CALGB-A211102, NCT01905046
Acquisition of Breast Mammography Images
Phase: Phase III
Type: Diagnostic, Health services research, Screening
Age: 18 and over
Trial IDs: FMSU2013-004A, NCI-2014-02323, NCT02156258
Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer Survivors
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Age: 25 and over
Trial IDs: 08218, NCI-2010-01976, 115422, NCT01196936
Dasatinib in Preventing Second Primary Breast Cancer in Women with Estrogen Receptor Negative Breast Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Age: 18 and over
Trial IDs: 2010-0794, NCI-2012-00037, KG09 1020, Susan Komen Foundation Grant Number(s): KG09 1020, NCT01471106
Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax
Phase: Phase II
Type: Prevention
Age: 18 and over
Trial IDs: 368255, NCI-2015-00026, 1137008 / 20130058, NCT01570036
NSAID Effects on Clinical and Imaging Breast Biomarkers
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Age: 75 and under
Trial IDs: 1RO1 CA1615301A1, NCI-2015-01399, 12-0080-04, 676847, NCT01761877
Docosahexaenoic Acid in Preventing Recurrence in Breast Cancer Survivors
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Age: 18 and over
Trial IDs: 2011-0766, NCI-2013-00859, 12-267, 12-474, AAAK6752, CUMC: AAAK6752, DFCI:12- 474, H-33017, MDACC- 2011-0766, MSKCC-12-267, N01-CN-2012-00034, MDA10-16-01, NCT01849250
Metformin Hydrochloride in Reducing Obesity-Associated Breast Cancer Risk
Phase: Phase II
Type: Prevention
Age: 30 to 45
Trial IDs: 1300000596, NCI-2015-01211, 1300000596A024, NCT02028221
Exercise Intervention in Preventing Breast Cancer Recurrence in Postmenopausal Breast Cancer Survivors
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention, Supportive care
Age: Not specified
Trial IDs: 14135, NCI-2014-01876, 112656, 115021, 116981, 119174, NCT02235051
Phase II Trial of Combination Immunotherapy With NeuVax and Trastuzumab in High-risk HER2+ Breast Cancer Patients
Phase: Phase II
Type: Prevention
Age: 18 and over
Trial IDs: 2014-0443, NCI-2015-00033, NCT02297698
Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Age: 18 and over
Trial IDs: NCI 2013-01-03, NCI-2014-02412, HHSN2612201200035I, N01-CN-2012-00035, NWU2013-01-03, NCT02314156
Electroacupuncture in Preventing Neuropathy Related to Paclitaxel Therapy in Patients With Stage I-III Breast Cancer
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Age: 21 and over
Trial IDs: AAAE7054, NCI-2011-01142, NCT01163682
Breast-Conserving Surgery and Radiation Therapy in Treating Patients with Multiple Ipsilateral Breast Cancer
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Age: 40 and over
Trial IDs: Z11102, NCI-2012-00707, ACOSOG-Z11102, CDR0000728605, NCT01556243
Metformin Hydrochloride vs. Placebo in Overweight or Obese Patients at Elevated Risk for Breast Cancer
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Age: 18 to 75
Trial IDs: IUCRO-0365, NCI-2013-00422, NCT01793948
Diffusion-Weighted MRI in Imaging Patients at High Risk for Breast Cancer
Phase: No phase specified
Type: Screening
Age: 21 and older
Trial IDs: LCCC1236, NCI-2014-02425, 12-2327, NCT01938157
Curcumin in Reducing Inflammatory Changes in Breast Tissue in Obese Patients At High Risk for Breast Cancer
Phase: No phase specified
Type: Prevention
Age: 19 and over
Trial IDs: OSU-13034, NCI-2013-01199, 2013C0039, NCT01975363
Time Restricted Diet in Obese or Overweight Pre or Postmenopausal Participants
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Age: 18 to 65
Trial IDs: NU 13CC12, NCI-2014-01094, STU00091568, NCT02154984
Bioimpedance Spectroscopy Versus Tape Measure in Prevention of Lymphedema
Phase: No phase specified
Type: Prevention
Age: 18 and over
Trial IDs: VICCBRE1438, NCI-2014-01427, NCT02167659
Energy Balance Interventions in Increasing Physical Activity in Cancer Survivors or High-Risk Family Members
Phase: No phase specified
Type: Prevention
Age: 18 and over
Trial IDs: 2014-0230, NCI-2015-00095, NCT02194387
CESM in Screening Women at High Risk for Breast Cancer
Phase: No phase specified
Type: Screening
Age: 30 and over
Trial IDs: 14-225, NCI-2014-02355, NCT02275871
Omega-3 Fatty Acids in Preventing Recurrence in Patients with Hormone Receptor-Negative or HER2-Positive Stage 0-III Breast Cancer That Have Completed Treatment
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Age: 18 and over
Trial IDs: OSU-13130/2013C0068, NCI-2014-02036, 2013C0068, OSU-13130, NCT02295059
Start Over